Medtech CEOs Predict Diminished Role For Hospitals In The Future Of Surgery
Surgical volumes are rebounding close to pre-pandemic levels, but the volumes at hospitals may never completely rebound, according to medtech CEOs participating in a discussion at The Virtual MedTech Conference.
You may also be interested in...
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
Led by the Mako surgical robot, Stryker’s third-quarter sales exceeded Wall Street analysts’ expectations as it prepares to complete the $4bn acquisition of Wright Medical.
Intuitive reported better-than-expected second-quarter revenues and announced plans to roll out a new extended use program for certain surgical instruments, but remains cautious for the second half amid the COVID-19 pandemic.